The DOI matches its Crossref record; 84 of the 88 references it cites were found in a registry or an index.
Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction
Open accessAbstract
The expression of IL-1 is elevated in the CNS in diverse neurodegenerative disorders, including Alzheimer's disease. The hypothesis was tested that IL-1 beta renders neurons vulnerable to degeneration by interfering with BDNF-induced neuroprotection. In trophic support-deprived neurons, IL-1 beta compromised the PI3-K/Akt pathway-mediated protection by BDNF and suppressed Akt activation. The effect was specific as in addition to Akt, the activation of MAPK/ERK, but not PLC gamma, was decreased. Activation of CREB, a target of these signaling pathways, was severely depressed by IL-1 beta. As the cytokine did not influence TrkB receptor and PLC gamma activation, IL-1 beta might have interfered with BDNF signaling at the docking step conveying activation to the PI3-K/Akt and Ras/MAPK pathways. Indeed, IL-1 beta suppressed the activation of the respective scaffolding proteins IRS-1 and Shc; this effect might involve ceramide generation. IL-1-induced interference with BDNF neuroprotection and signal transduction was corrected, in part, by ceramide production inhibitors and mimicked by the cell-permeable C2-ceramide. These results suggest that IL-1 beta places neurons at risk by interfering with BDNF signaling involving a ceramide-associated mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFN-alpha administration has also been found to decrease systemic BDNF levels in humans (Kenis et al., 2010, Lotrich et al., 2013) (see Figure 1), as can other inflammatory cytokines and LPS injections (Tong et al., 2008, Cortese et al., 2011) (Guan and Fang, 2006).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Tong et al., 2008
Citations
Cites
2 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedVenters, H., Tang, Q., Liu, Q., VanHoy, R. W., Dantzer, R., & Kelley, K. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9879 · Cited by 187
RetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Trk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 2×
“BDNF activates not only the PI3-K/Akt, but also other major signaling pathways [28].”
BackgroundBonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Research works printed but not linked: 1
- Nicoll, 2000, Association of interleukin-1 gene polymorphisms with Alzheimer's disease, Ann. Neurol., 47, 365, 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G · DOI
Cited by
Sorted by citations
Exercise builds brain health: key roles of growth factor cascades and inflammation
Cotman, C. W., Berchtold, N. C., & Christie, L.-A. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.011 · Cited by 2,268
Self-citationInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Early-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
Cribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499
Self-citationKubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Hampel, H., Caraci, F., Cuello, A. C., Caruso, G., Nisticò, R., Corbo, M., Baldacci, F., Toschi, N., Garaci, F., Chiesa, P. A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00456 · Cited by 360
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Caraci, F., Copani, A., Nicoletti, F., & Drago, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.022 · Cited by 325
Anisman, H. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0902 · Cited by 292
Patterson, S. L. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.020 · Cited by 291
Dinel, A., André, C., Aubert, A., Ferreira, G., Layé, S., & Castanon, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024325 · Cited by 275
Tong, L., Prieto, G. A., Kramár, E. A., Smith, E. D., Cribbs, D. H., Lynch, G., & Cotman, C. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1253-12.2012 · Cited by 254
Self-citationWang, Z.-H., Xiang, J., Liu, X., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Wu, S., Wang, J.-Z., & Ye, K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.054 · Cited by 238
Jurgens, H. A., Amancherla, K., & Johnson, R. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6389-11.2012 · Cited by 243
Hosseini, S., Wilk, E., Michaelsen-Preusse, K., Gerhauser, I., Baumgärtner, W., Geffers, R., Schughart, K., & Korte, M. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1740-17.2018 · Cited by 236
Caspase-3 activation as a bifurcation point between plasticity and cell death
Snigdha, S., Smith, E. D., Prieto, G. A., & Cotman, C. W. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1057-5 · Cited by 227
Self-citationBarrientos, R. M., Frank, M. G., Hein, A. M., Higgins, E. A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.07.002 · Cited by 226
Zhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195
The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
Calderaro, A., Patanè, G. T., Tellone, E., Barreca, D., Ficarra, S., Misiti, F., & Laganà, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314835 · Cited by 208
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
Dysregulated neuronal–microglial cross-talk during aging, stress and inflammation
Jurgens, H. A., & Johnson, R. W. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.014 · Cited by 179
Brain-derived neurotrophic factor and inflammation in depression: Pathogenic partners in crime?
Porter, G. A., & O’Connor, J. C. (2022) · World Journal of Psychiatry · doi:10.5498/wjp.v12.i1.77 · Cited by 188
Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.007 · Cited by 172
Maes, M. H. J., Song, C., & Yirmiya, R. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.718331 · Cited by 158
Qosa, H., Batarseh, Y. S., Mohyeldin, M. M., Sayed, K. A. E., Keller, J. N., & Kaddoumi, A. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00190 · Cited by 161
The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson’s Disease in Rats
Mao, Z., Liu, C., Ji, S., Yang, Q., Ye, H., Han, H., & Xue, Z. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2185-0 · Cited by 155
Golia, M. T., Poggini, S., Alboni, S., Garofalo, S., Albanese, N. C., Viglione, A., Ajmone‐Cat, M. A., St-Pierre, A., Brunello, N., Limatola, C., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.003 · Cited by 161
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
Dourado, N. S., Souza, C. D. S., de Almeida, M. M. A., da Silva, A. B., dos Santos, B. L., da Silva, V. D. A., de Assis, A. M., da Silva, J. S., Souza, D. O., Costa, M. D. F. D., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00119 · Cited by 159
Interleukin‐1β: a bridge between inflammation and excitotoxicity?
Fogal, B., & Hewett, S. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05315.x · Cited by 151
Hsu, Y.-C., Huang, Y.-Y., Tsai, S., Kuo, Y., Lin, J., Ho, H.-H., Chen, J., Hsia, K.-C., & Sun, Y. (2023) · Nutrients · doi:10.3390/nu16010016 · Cited by 156
The Future of Precision Medicine in the Cure of Alzheimer’s Disease
Arafah, A., Khatoon, S., Rasool, I., Khan, A., Rather, M. A., Abujabal, K. A., Faqih, Y. A. H., Rashid, H., Rashid, S. M., Bilal Ahmad, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020335 · Cited by 133
A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review
Notaras, M. J., Hill, R., & van den Buuse, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.016 · Cited by 137
Prieto, G. A., Snigdha, S., Baglietto-Vargas, D., Smith, E. D., Berchtold, N. C., Tong, L., Ajami, D., LaFerla, F. M., Rebek, J., & Cotman, C. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514486112 · Cited by 126
Self-citationBegni, V., Riva, M. A., & Cattaneo, A. (2016) · Clinical Science · doi:10.1042/cs20160009 · Cited by 129
The putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 126
Interleukin-1β in Central Nervous System Injury and Repair.
Hewett, S. J., Jackman, N. A., & Claycomb, R. (2012) · PubMed · Cited by 121
Moody, L., Chen, H., & Pan, Y. (2017) · Advances in Nutrition · doi:10.3945/an.116.014209 · Cited by 126
TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse
Prieto, G. A., Tong, L., Smith, E. D., & Cotman, C. W. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2517-8 · Cited by 121
Self-citationPhysical Activity, Stress Reduction, and Mood: Insight into Immunological Mechanisms
Hamer, M., Endrighi, R., & Poole, L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_5 · Cited by 122
Infectious disease-associated encephalopathies
Barbosa‐Silva, M. C., Lima, M. N., Battaglini, D., Robba, C., Pelosi, P. P., Rocco, P. R. M., & Maron‐Gutierrez, T. (2021) · Critical Care · doi:10.1186/s13054-021-03659-6 · Cited by 122
Loreto, S. D., Falone, S., Caracciolo, V., Sebastiani, P., D'Alessandro, A., Mirabilio, A., Zimmitti, V., & Amicarelli, F. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21674 · Cited by 105
Bilbo, S. D., Barrientos, R. M., Eads, A. S., Northcutt, A. L., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.10.003 · Cited by 104
Cao, Z., Yang, X., Zhang, H., Wang, H., Huang, W., Xu, F., Zhuang, C., Wang, X., & Li, Y. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.02.092 · Cited by 98
Batarseh, Y. S., Bharate, S. S., Kumar, V., Kumar, A., Vishwakarma, R. A., Bharate, S. B., & Kaddoumi, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00101 · Cited by 100
Markham, A., Cameron, I., Bains, R. S., Franklin, P., Kiss, J., Schwendimann, L., Gressèns, P., & Spedding, M. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07965.x · Cited by 98
Adipocyte Ceramides—The Nexus of Inflammation and Metabolic Disease
Chaurasia, B., Talbot, C. L., & Summers, S. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576347 · Cited by 99
Olive Oil and the Hallmarks of Aging
Fernández-del-Río, L., Gutiérrez-Casado, E., Varela‐López, A., & Villalba, J. M. (2016) · Molecules · doi:10.3390/molecules21020163 · Cited by 100
Jurgens, H. A., & Johnson, R. W. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.015 · Cited by 95
Hippocampal dysfunctions in tumor-bearing mice
Yang, M., Kim, J., Kim, J., Kim, S., Kim, J.-C., Kang, M., Jung, U., Shin, T., Wang, H., & Moon, C. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.10.022 · Cited by 97
Lotrich, F. E., Albusaysi, S., & Ferrell, R. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.263 · Cited by 92
Smith, E. D., Prieto, G. A., Tong, L., Sears‐Kraxberger, I., Rice, J. D., Steward, O., & Cotman, C. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568659 · Cited by 94
Self-citationArakawa, S., Shirayama, Y., Fujita, Y., Ishima, T., Horio, M., Muneoka, K. T., Iyo, M., & Hashimoto, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.008 · Cited by 90
Numakawa, T., Richards, M., Nakajima, S., Adachi, N., Furuta, M., Odaka, H., & Kunugi, H. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00136 · Cited by 86
Normal‑tension glaucoma: Pathogenesis and genetics (Review)
Trivli, A., Koliarakis, I., Terzidou, C., Goulielmos, G. N., Siganos, C. S., Spandidos, D. A., Dalianis, G., & Detorakis, Ε. T. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7011 · Cited by 86
Pugazhenthi, S., Zhang, Y., Bouchard, R. J., & Mahaffey, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069585 · Cited by 87
Anisman, H., Gibb, J., & Hayley, S. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1166-z · Cited by 87
Dinel, A., André, C., Aubert, A., Ferreira, G., Layé, S., & Castanon, N. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.014 · Cited by 89
Lotrich, F. E., Butters, M. A., Aizenstein, H. J., Marron, M. M., Reynolds, C. F., & Gildengers, A. G. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4048 · Cited by 85
Park, S., Kang, M.-J., & Han, J. (2018) · Molecular Brain · doi:10.1186/s13041-018-0383-6 · Cited by 83
Batarseh, Y. S., & Kaddoumi, A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.12.006 · Cited by 83
Ben-Menachem-Zidon, O., Ben-Menahem, Y., Ben-Hur, T., & Yirmiya, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.208 · Cited by 81
Boato, F., Rosenberger, K., Nelissen, S., Geboes, L., Peters, E. M. J., Nitsch, R., & Hendrix, S. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-6 · Cited by 73
Cortese, G. P., & Bürger, C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.027 · Cited by 77
Hriţcu, L., & Gorgan, L. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.016 · Cited by 70
Ng, C. Y. H., Tay, S. H., McIntyre, R. S., Ho, R., Tam, W., & Ho, C. S. H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.05.108 · Cited by 73
Rus, G. Z., dos Santos, M. A. B., Abelaira, H. M., Ribeiro, K. F., Petronilho, F. C., Vuolo, F. S., Colpo, G. D., Pfaffenseller, B., Kapczinski, F. P., Dal‐Pizzol, F., et al. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.044 · Cited by 71
Liang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12010184 · Cited by 68
Zhao, J., Luo, D., Liang, Z., Lao, L., & Rong, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9870-x · Cited by 67
Moy, G. A., & McNay, E. C. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.11.008 · Cited by 68
The road to precision medicine: Eliminating the “One Size Fits All” approach in Alzheimer’s disease
Behl, T., Kaur, I., Sehgal, A., Singh, S., Albarrati, A., Albratty, M., Najmi, A., Meraya, A. M., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113337 · Cited by 67
Nock, N. L., Minnes, S., & Alberts, J. L. (2017) · Birth Defects Research · doi:10.1002/bdr2.1182 · Cited by 61
Marek, G. J. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_480 · Cited by 66
Effect of childhood maltreatment and brain-derived neurotrophic factor on brain morphology
van Velzen, L. S., Schmaal, L., Jansen, R., Milaneschi, Y., Opmeer, E. M., Elzinga, B. M., van der Wee, N. J. A., Veltman, D. J., & Penninx, B. W. J. H. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw086 · Cited by 58
Bayati, A., Ayoubi, R., Aguila, A., Zorca, C. E., Deyab, G., Han, C., Recinto, S. J., Nguyen, E., Rocha, C., Maussion, G., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01775-4 · Cited by 67
Interleukin-1 beta and neurotrophin-3 synergistically promote neurite growth in vitro
Boato, F., Hechler, D., Rosenberger, K., Lüdecke, D., Peters, E. M. J., Nitsch, R., & Hendrix, S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-183 · Cited by 58
Dong, Y., Pu, K., Duan, W., Chen, H., Chen, L., & Wang, Y. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0455-7 · Cited by 58
The current research status of normal tension glaucoma
Mi, X.-S., Yuan, T., & So, K. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s67263 · Cited by 59
Barnes, P., Kirtley, A., & Thomas, K. L. (2010) · Hippocampus · doi:10.1002/hipo.20879 · Cited by 56
Yang, Y., Fan, L., Peng, Y., Peng, C., & Li, X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.220 · Cited by 56
Bardou, I., Kaercher, R. M., Brothers, H. M., Hopp, S. C., Royer, S. E., & Wenk, G. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.006 · Cited by 56
Turovskaya, M. V., Gaidin, S. G., Vedunova, M. V., Babaev, A. A., & Turovsky, E. A. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00480-z · Cited by 55
Wang, N., Feng, B., Hu, B., Cheng, Y., Guo, Y., & Qian, H. (2021) · Food & Function · doi:10.1039/d1fo02216d · Cited by 55
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Ritsner, M. S. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5 · Cited by 50
IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking
Carlos, A. J., Tong, L., Prieto, G. A., & Cotman, C. W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0803-z · Cited by 52
Self-citationExercise and Physical Therapy in Early Management of Parkinson Disease
Alonso‐Frech, F., Sanahuja, J. J., & Rodriguez, A. M. (2011) · The Neurologist · doi:10.1097/nrl.0b013e31823968ec · Cited by 47
Modulation of Neural Networks by Interleukin-1
Nemeth, D. P., & Quan, N. (2020) · Brain Plasticity · doi:10.3233/bpl-200109 · Cited by 46
Allan, N. P., Yamamoto, B. Y., Kunihiro, B. P., Nunokawa, C. K. L., Rubas, N. C., Wells, R. K., Umeda, L., Phankitnirundorn, K., Torres, A., Peres, R., et al. (2024) · Nutrients · doi:10.3390/nu16101401 · Cited by 44
Prenatal inflammation and risk for schizophrenia: A role for immune proteins in neurodevelopment
Allswede, D. M., & Cannon, T. D. (2018) · Development and Psychopathology · doi:10.1017/s0954579418000317 · Cited by 46
Neuroimmune System as a Driving Force for Plasticity Following CNS Injury
O’Reilly, M. L., & Tom, V. J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00187 · Cited by 44
Chen, J.-J., Wang, T., An, C.-D., Jiang, C., Zhao, J., & Li, S. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0017 · Cited by 40
Règue, M., Poilbout, C., Martin, V., Franc, B., Lanfumey, L., & Mongeau, R. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0431-8 · Cited by 41
Merriman, J. D., Aouizerat, B. E., Cataldo, J. K., Dunn, L. B., Cooper, B. A., West, C. M., Paul, S. M., Baggott, C., Dhruva, A., Kober, K. M., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.11.003 · Cited by 40
Increased levels of plasma IL-1b and BDNF can predict resistant depression patients
Uint, L., Bastos, G. M., Thurow, H. S., Borges, J. B., Hirata, T. D. C., França, J. Í. D., Hirata, M. H., & Sousa, A. (2019) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.65.3.361 · Cited by 41
Huckans, M. S., Fuller, B. E., Olavarria, H., Sasaki, A. W., Chang, M., Flora, K. D., Kolessar, M., Kříž, D., Anderson, J. R., Vandenbark, A. A., et al. (2013) · Brain and Behavior · doi:10.1002/brb3.200 · Cited by 41
Wassouf, Z., & Schulze-Hentrich, J. M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14787 · Cited by 36
Numakawa, T., & Kajihara, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031596 · Cited by 35
Tong, L., Prieto, G. A., & Cotman, C. W. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1158-9 · Cited by 38
Self-citationKimono, D. A., Bose, D., Seth, R. K., Mondal, A., Saha, P., Janulewicz, P. A., Sullivan, K. A., Lasley, S. M., Horner, R. D., Klimas, N. G., et al. (2020) · Neuroscience Insights · doi:10.1177/2633105520942480 · Cited by 38
Seo, M. K., Lee, J. G., & Park, S. W. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.12.033 · Cited by 39
Metadata
- Authors
- Tong, L., Balazs, R., Soiampornkul, R., Thangnipon, W., & Cotman, C. W.
- Affiliations
- University of California, Irvine (US)
- Mahidol University (TH)
- Corresponding author
- Tong, Liqi
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 29
- Issue
- 9
- Pages
- 1380-1393
- ISSN
- 0197-4580 (ISSN-L)
- PMC
- PMC4052889
- OpenAlex
- W2015851283
- Cited by
- 222
- References
- 88
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 18 · 2023: 12 · 2022: 13 · 2021: 12 · 2020: 16 · 2019: 8 · 2018: 14 · 2017: 18 · 2016: 13 · 2015: 8 · 2014: 11 · 2013: 18 · 2012: 15
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P01AG000538)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- IL-1β, brain-derived neurotrophic factor, neuroprotection, PI3K/Akt signaling, ERK signaling, CREB activation, TrkB receptor, IRS-1, Shc, ceramide, neurodegeneration, Alzheimer's disease, neuroinflammation, signal transduction
- MeSH terms
- Animals, Cells, Cultured, Cerebral Cortex, Neurons, Signal Transduction, Apoptosis, Brain-Derived Neurotrophic Factor, Rats, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review